A Phase 1/2 study of the safety, tolorability and efficacy of INCB24360 administered in combination with Nivolumab in select advanced cancers.
Administered By
Awarded By
Contributors
- Mettu, Niharika Bansal Principal Investigator
Start/End
- April 1, 2015 - March 30, 2020